(Q37577890)

21 August 2017

1 reference

title

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

21 August 2017

main subject

1 reference

Benjamin F Chong

1

1 reference

21 August 2017

Chandra Mohan

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Expert Opinion on Therapeutic Targets

21 August 2017

published in

1 reference

21 August 2017

volume

13

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

1147-1153

1 reference

Systemic lupus erythematosus

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Regulation of B cell tolerance by the lupus susceptibility gene Ly108.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

An open study of B lymphocyte depletion in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The resistance of activated T-cells from SLE patients to apoptosis induced by human thymic stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Treatment of murine lupus with CTLA4Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Lymphocyte homing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Chemokines and chemokine receptors in leukocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Identification and expression of novel isoforms of human stromal cell-derived factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Efficient inhibition of SDF-1alpha-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The significance of cancer cell expression of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Pharmacokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903196761

10.1517/14728220903196761

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference